• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Cohance Lifesciences Limited — Updates, 04-02-2026: General Updates

    04-02-2026 | 11:17 am

    Cohance Lifesciences received a USFDA Warning Letter for its Nacharam facility, following an earlier OAI classification. US revenues from this unit contributed less than 2% of consolidated revenues in FY2025, with EBITDA below 1%, indicating no material financial impact.

    No comments yet. Be the first to comment!

    All announcements from Cohance Lifesciences Limited